Abstract
The substances utilized for what is commonly referred to as ' protein
therapeutics' have one thing in common --- they are all composed primarily of
a-amino acids; and these a-amino acids are linked together by a distinct
chemical bond known as a "peptide" bond. Used in a variety of areas of
medicine, they are among the most interesting pharmaceutical markets.
Above-Average Growth Rate
What makes protein therapeutics interesting? The market for protein-based
therapeutics is one that is significant in its size and growing at a rate that
is well above what one would call "average" for the
therapeutics/pharmaceuticals industry. This makes them a continual topic of
interest for researchers examining the pharmaceutical markets.
The substances detailed in this report include:
- AntiThrombins
- Cytokines
- Growth Hormones
- Hematopoietics
- Insulin
- Monoclonal Antibodies
- Plasma Proteins
- Vaccines
- Miscellaneous
For each of these categories, market forecasts to 2012 are provided.
A Thriving Field with Abundant Competition
At the present time, there are at least 213 companies active in various
aspects of protein-based therapeutics development. This is at, or greater
than, the saturation level for the industry at this time. Presently, the
industry is at equilibrium --- companies at the lower end leaving and entering
at about the same rate and a small number of protein-based therapeutics
companies being acquired by the more-established participants.
This Kalorama Report Answers Key Questions about the Makret
Dr. Kenneth Krul, PhD has surveyed the marketplace and in this volume reviews
the key findings and conclusions about the current state of protein
therapeutics. The report features forecasts for the main groups of protein
therapeutics. Among the questions answered in this report:
- How large is the market; how fast is the market growing; and is such
growth sustainable?
- What does the pipeline of products that are expected to sustain this
growth look like?
- To what extent is the growth in this market dependent on production
introduction versus price-point for these products?
- Is the development pipeline filled with similar products or direct
alternatives such that product competition will be strong enough to
significantly affect price-point?
- What is the industry structure like? What changes can be expected in the
structure of the industry and how will these changes affect market size and
growth?
| 
View Cart
